GENSCRIPT BIO

01548

----

H1 2026 Earnings

Financial report interval: 2025.12.30 - 2026.06.30

Overview: GENSCRIPT BIO(01548) the Revenue is 3.17 B (-22.16%), Beat estimate;the EBIT is 393.45 M (-71.95%), Beat estimate;the EPS is -0.464 (-173.8%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

3.17B22.16%

3.01B26.06%

+0.16B3.90%

EBITExceed expectations

0.39B71.95%

0.17B87.84%

+0.22B15.89%

EPSMiss expectations

-0.4643173.83%

0100.00%

-0.4643273.83%

Upcoming earnings report - Q3 FY2026

Available dateNov 16, 2026

Estimate Revenue--

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: HKD

Quarterly

EBIT

ActualEstimateUnit: HKD

Quarterly

Net income

ActualEstimateUnit: HKD

Quarterly

EPS

ActualEstimateUnit: HKD

Quarterly